Pregnancy May Alter Brain Function, Leading to Changes in Fear Memory
Recent research suggests that the cognitive changes often experienced by mothers following childbirth, commonly referred to as "mom brain," may be a direct result of alterations in brain structure and function induced by pregnancy. A new study conducted at Northeastern University provides further insight into these neurological shifts, specifically identifying a reduction in fear memory persistence in postpartum rats.
The study, detailed in a recent publication, focuses on the period during pregnancy and immediately after birth, a phase that has received comparatively limited long-term scientific investigation. Researchers emphasize the unique opportunity to study these neurological changes as they occur during pregnancy, offering a deeper understanding of the hormonal influences shaping the developing maternal brain.
The research team employed a Pavlovian conditioning paradigm, training rats to associate specific sounds with mild electric shocks. They then compared the fear responses of pregnant rats, postpartum rats, and a control group of non-pregnant rats. The findings revealed that both pregnant and postpartum rats exhibited a diminished fear response to the conditioned sounds, suggesting a potential disruption in the consolidation of fear memories. In contrast, the control group continued to display typical fear responses, indicating a significant difference in neural processing.
Professor of psychology and chair of the research team, Rebecca Shansky, explains that the observed changes are not simply due to learned behavior. She notes that the pregnant and postpartum rats were less likely to engage in fear behaviors they had previously learned, even when confronted with the familiar cues. This suggests a more fundamental alteration in how their brains process and retain fear memories.
The researchers hypothesize that allopregnanolone, a steroid hormone produced in higher quantities during late pregnancy in both humans and rats, plays a crucial role in these neurological changes. Allopregnanolone is known to influence mood regulation, and its elevated levels during pregnancy may contribute to the observed reduction in fear memory. To investigate this further, the team administered a drug called finasteride to pregnant rats during the final days of pregnancy. Finasteride prevents the conversion of progesterone into allopregnanolone, effectively lowering its levels.
Interestingly, the rats treated with finasteride exhibited a restoration of their fear memories, but only in the non-darting rats – those that freeze in response to fear. This suggests that the impact of allopregnanolone on fear memory consolidation may be more pronounced in certain neural pathways. Furthermore, the study found that the rats with lowered allopregnanolone levels experienced delayed births and smaller litter sizes, indicating a broader impact on reproductive physiology.
While the study provides compelling evidence for a link between pregnancy and altered fear memory processing, researchers acknowledge that further investigation is needed. Questions remain about the precise mechanisms by which allopregnanolone influences the brain and whether these changes are truly long-lasting. To address these questions, the team plans future experiments using a virus to block the receptors in the brain that allopregnanolone typically binds to, allowing researchers to observe the effects of normal allopregnanolone levels.
Shansky emphasizes the fundamental question driving their research: how does pregnancy fundamentally alter the brain in a long-term, stable manner? The findings from this study offer a significant step towards understanding the neurological underpinnings of postpartum cognitive changes and may have implications for understanding and addressing conditions like postpartum depression and anxiety.
